| Patents for C07K 19 - Hybrid peptides (29,428) |
|---|
| 09/30/2010 | WO2010111597A2 Immunodominant compositions and methods of use therefor |
| 09/30/2010 | WO2010110503A1 INTERFERON-α (IFN-α) FUSED PROTEIN HAVING IFN-α AND CYTOPLASMIC TRANSDUCTION PEPTIDE (CTP) |
| 09/30/2010 | WO2010091441A9 Stable, functional chimeric cellobiohydrolases |
| 09/30/2010 | WO2010080248A3 Peptides that bind eukaryotic translation initiation factor 4e |
| 09/30/2010 | US20100249427 Bioluminescent protease assay |
| 09/30/2010 | US20100249372 Botulinum neurotoxin a receptor and the use thereof |
| 09/30/2010 | US20100249034 Gfralpha3 and its uses |
| 09/30/2010 | US20100248360 Nucleotide sequences coding g protein-coupled receptor for use in identifying modulators of taste transductance; artificial sweetners |
| 09/30/2010 | US20100247574 CHIMERIC NEWCASTLE DISEASE VIRUS VLPs |
| 09/30/2010 | US20100247518 Modified proteins, designer toxins, and methods of making thereof |
| 09/29/2010 | EP2233576A1 Modified coagulation factor VIIa with extended half-life |
| 09/29/2010 | EP2233149A1 Combination of BLYS inhibition and anti-CD20 agents for treatment of autoimmune disease |
| 09/29/2010 | EP2231709A1 Bivalent, bispecific antibodies |
| 09/29/2010 | EP2231706A1 Biokinetics of fast-clearing polypeptides |
| 09/29/2010 | EP1692159B1 Tgf-beta1 binding and supported peptides |
| 09/29/2010 | CN1948339B Preparation and purification of telomerase activity inhibition protein |
| 09/29/2010 | CN101848939A Protein G-oligonucleotide conjugate |
| 09/29/2010 | CN101848938A Modified plant defensin |
| 09/29/2010 | CN101848926A Peptide capable of binding to immunoglobulin |
| 09/29/2010 | CN101848730A Capsid proteins and uses therefore |
| 09/29/2010 | CN101845099A Long-acting analgesic peptide and application thereof |
| 09/29/2010 | CN101845098A Crystal of rat RANK/RANKL extracellular compound, preparation method and application thereof |
| 09/29/2010 | CN101843895A Cytokine receptor ZCYTOR17 multimers |
| 09/29/2010 | CN101177453B Recombined chimeric antibody against human tumor necrosis factor alpha |
| 09/28/2010 | US7803923 Growth differentiation factor-8 binding agents for treatment of metabolic, nervous system, muscular, bone , urogenital and inflammatory disorders; for treating muscle-wasting disorders and metabolic disorders including diabetes and obesity |
| 09/28/2010 | US7803904 Mucosal vascular addressing and uses thereof |
| 09/28/2010 | US7803772 Administering a polypeptide having at least one of anti-angiogenic, tumor-suppressive, or anti-migratory activity, but does not have stimulation of cell proliferation activity |
| 09/28/2010 | US7803749 Prevent signal transduction passageways; kinase inhibitor; modulate immunology response |
| 09/28/2010 | US7803739 Substrates and assays for β-secretase |
| 09/28/2010 | US7803602 Method for overexpression of zwitterionic polysaccharides |
| 09/28/2010 | US7803387 With proteins of nisseria and purification of domains and gene expression of oligopeptides of ser, lys, ala, glu, gly and met |
| 09/28/2010 | US7803361 Decreasing solid tumor size in a cancer patient by administering an interleukin-2 mutant with reduced vasopermeability activity compared to a wildtype form, and being Arg38Trp, wherein said wildtype form is human IL-2 mutant and the IL-2 mutant is not linked to an antibody. |
| 09/28/2010 | CA2380298C Antibody molecules having specificity for human tumor necrosis factor alpha, and use thereof |
| 09/28/2010 | CA2208783C Methods for producing immunoglobulins containing protection proteins in plants and their use |
| 09/23/2010 | WO2010107825A2 Compositions and methods comprising histidyl-trna synthetase splice variants having non-canonical biological activities |
| 09/23/2010 | WO2010105573A1 Anti-angiogenic fusion proteins |
| 09/23/2010 | WO2010062697A3 Membrane-integrated viral dna-packaging motor protein connector biosensor for dna sequencing and other uses |
| 09/23/2010 | US20100240873 Ligand (act-4-l) to a receptor on the surface of activated cd4+ tcells |
| 09/23/2010 | US20100240590 Peptides and related molecules that bind to tall-1 |
| 09/23/2010 | US20100239530 Ifnar2 mutants, their production and use |
| 09/23/2010 | CA2755784A1 Compositions and methods comprising histidyl-trna synthetase splice variants having non-canonical biological activities |
| 09/23/2010 | CA2755336A1 Carrier immunoglobulins and uses thereof |
| 09/23/2010 | CA2748889A1 Compositions and methods for blood-brain barrier delivery of igg-decoy receptor fusion proteins |
| 09/22/2010 | EP2230309A1 Gene capable of increasing the production of oil-and-fat in plant, and use thereof |
| 09/22/2010 | EP2230308A1 Antibody molecules having specificity for human tumor necrosis factor alpha, and use thereof |
| 09/22/2010 | EP2230299A1 Novel cytokine ZCYTOR17 ligand |
| 09/22/2010 | EP2230257A1 Method for the purification of albumin conjugates |
| 09/22/2010 | EP2229437A1 Engineering zymogen for conditional toxicity |
| 09/22/2010 | EP2229410A2 Aglycosylated immunoglobulin mutants |
| 09/22/2010 | EP1335938B1 Apolipoprotein construct |
| 09/22/2010 | CN101842490A Antigenic compositions and use of same in the targeted delivery of nucleic acids |
| 09/22/2010 | CN101838660A Mycobacterium tuberculosis recombinant fusion protein and application thereof |
| 09/22/2010 | CN101838330A Sterilized/permeability-strengthened protein-human acid fibroblast growth factor fusion protein, preparation method and application thereof |
| 09/22/2010 | CN101838329A Anti-angiogenesis fusion protein |
| 09/21/2010 | US7799905 T1R1 nucleic acid sequences and vectors containing same |
| 09/21/2010 | US7799899 Compositions and methods relating to STOP-1 |
| 09/21/2010 | US7799759 albumin fusion proteins. Nucleic acid molecules encoding the albumin fusion proteins of the invention are also encompassed by the invention, as are vectors containing these nucleic acids, host cells transformed with these nucleic acids vectors, and methods of making the albumin fusion proteins |
| 09/21/2010 | US7799566 Cyclin D polynucleotides, polypeptides and uses thereof |
| 09/21/2010 | US7799543 Human tumor necrosis factor receptor polynucleotides |
| 09/21/2010 | US7799541 for Systemic Inflammatory Response Syndrome (SIRS), including severe sepsis, septic shock and sepsis related to cardiac dysfunction |
| 09/21/2010 | CA2370493C Peptides and assays for the diagnosis of lyme disease and compositions useful for the prevention thereof |
| 09/16/2010 | WO2010104749A2 Antigen presenting cell targeted cancer vaccines |
| 09/16/2010 | WO2010104748A2 Antigen presenting cell targeted anti-viral vaccines |
| 09/16/2010 | WO2010104747A2 Antigen presenting cell targeted vaccines |
| 09/16/2010 | WO2010104357A2 Establishment of induced pluripotent stem cell using cell-permeable reprogramming transcription factor for customized stem cell therapy |
| 09/16/2010 | WO2010104124A1 Method for fluorescently labeling protein |
| 09/16/2010 | WO2010102518A1 Polymer of fusion proteins |
| 09/16/2010 | WO2010039224A3 Respiratory syncytial virus (rsv) sequences for protein expression and vaccines |
| 09/16/2010 | US20100234300 A purified pro-cytolytic peptide; used to treat localized and metastatic prostate cancer; administered intratumorally and/or intraprostatically |
| 09/16/2010 | US20100233169 Methods for treating obesity using fibroblast growth factor-Like polypeptides |
| 09/16/2010 | US20100233117 Adjuvant combination formulations |
| 09/16/2010 | US20100233079 Dual Variable Domain Immunoglobulins and Uses Thereof |
| 09/16/2010 | CA2754906A1 Antigen presenting cell targeted vaccines |
| 09/16/2010 | CA2754764A1 Antigen presenting cell targeted cancer vaccines |
| 09/16/2010 | CA2754743A1 Antigen presenting cell targeted anti-viral vaccines |
| 09/15/2010 | EP2228389A2 Antibodies against vascular endothelial growth factor 2 |
| 09/15/2010 | EP2228385A1 Chlamydia trachomatis genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection |
| 09/15/2010 | EP2228384A1 Chlamydia trachomatis genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection |
| 09/15/2010 | EP1931697B1 Il-17a and il-17f antagonists and methods of using the same |
| 09/15/2010 | EP1354196B1 Diagnostics, drug screening and treatment for cancer |
| 09/15/2010 | EP1250055B1 Immune modulation with death receptor-induced apoptosis |
| 09/15/2010 | CN101835796A Vaccine antigen capable of inducing cross-reacting and neutralizing antibody against high-risk-type human papillomavirus |
| 09/15/2010 | CN101830986A Fusion protein polymer |
| 09/15/2010 | CN101830985A Recombination protein of enterohemorrhagic Escherichia coli O157:H7Tir and Tccp |
| 09/15/2010 | CN101830984A Double-targeted hybrid polypeptide for tumor diagnosis and treatment |
| 09/15/2010 | CN101830983A Preparation and application of specific sequence-based aquaporin 4 high titer antibody |
| 09/15/2010 | CN101333258B Fusion polypeptide with antimicrobial and wound healing promoting function |
| 09/15/2010 | CN101245110B Recombined leukocyte inhibition factor and hirudo nipponica former peg-and-socket joint protein and pharmaceutical composition |
| 09/14/2010 | US7795407 Metastatic breast and colon cancer regulated genes |
| 09/14/2010 | US7795384 expressed with high efficiency and stability in host cells; suitable for high effectively producing short peptides without lysine residues; digesting the fusion protein with trypsinase and carboxypeptidase B, thereby forming peptides C1 and C2 |
| 09/14/2010 | US7794955 Transfecting a eukaryotic cell with nucleotide sequence, contacting cell with a candidate compound; determining distribution of expressed protein in cell by detecting the distribution of detectable moiety in cell; drug screening for their ability to interact with transmembrane proteins |
| 09/14/2010 | CA2322792C Polypeptides homologous to vegf and bmp1 |
| 09/14/2010 | CA2146693C Antibodies against epitopes with homology to self antigens, methods of preparation and applications thereof |
| 09/10/2010 | WO2010102277A2 Methods of diagnosing and treating prostate cancer characterized by ndrg1-erg fusion |
| 09/10/2010 | WO2010101355A2 Chimeric protein, method for manufacturing the same, nano-sensor in which the chimeric protein is fixed, and application thereof |
| 09/10/2010 | WO2010101248A1 Cell proliferation inhibitor and method for screening same |
| 09/10/2010 | WO2010064838A3 Cell permeable p53 recombinant protein, polynucleotide encoding the same, and anti-cancer composition containing the same as active ingredient |
| 09/09/2010 | US20100228007 Mhc-peptide complex binding ligands |
| 09/09/2010 | US20100226921 Methods for treating obesity using Fibroblast Growth Factor-Like Polypeptides |
| 09/08/2010 | EP2225280A1 Bivalent, bispecific antibodies |